BB Biotech: Why now could be a good time to invest

At the model portfolio stock BB Biotech (i), several positive factors are currently coming together. The Nasdaq Biotechnology Index is technically near the end of its consolidation that has been ongoing since August. At the same time, AI is accelerating the pace of innovation in the industry. BB Biotech offers a broad access to this potential new biotech cycle with currently 39 holdings. The stock now presents an attractive risk-reward ratio for an entry if one wants to engage in the biotechnology-AI revolution through the R&D level. In the Traderfox...